Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

To achieve the European Green Deal's goal of 25% organic agriculture by 2030, researchers argue that new genomic techniques ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our decentralized manufacturing strategy and rapid release testing, enables delivery ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Carrie Buck was raped, labeled an “imbecile,” and sterilized by order of the state — all in the name of genetic progress.

PHILADELPHIA, PA — Vittoria Biotherapeutics Inc. has announced its upcoming presentation at the 2025 American Society of ...

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

Researchers engineered a new therapeutically enhanced, naturally derived particle for powerful gene therapies to tackle our ...

Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States ...

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.